Detalhe da pesquisa
1.
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts.
Eur J Nucl Med Mol Imaging
; 51(3): 768-778, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823909
2.
Enhanced Therapeutic Effects of 177Lu-DOTA-M5A in Combination with Heat Shock Protein 90 Inhibitor Onalespib in Colorectal Cancer Xenografts.
Cancers (Basel)
; 15(17)2023 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37686514
3.
Photoactive immunoconjugates for targeted photodynamic therapy of cancer.
J Photochem Photobiol B
; 243: 112716, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126865
4.
In Vitro Characterization of 177Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer.
Front Oncol
; 12: 849338, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35433442
5.
Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib.
Front Oncol
; 10: 532285, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33102211